Literature DB >> 23868864

Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery.

Shang-Hsiu Hu1, Tsung-Ying Hsieh, Chin-Sheng Chiang, Po-Jung Chen, You-Yin Chen, Tsung-Lang Chiu, San-Yuan Chen.   

Abstract

Gene therapy holds promise to suppress carcinomas but still remains far removed from clinic because of the lack of a safe and effective delivery system. Besides enhancing transfection efficiency, the difficulty in gene therapy is how to deliver sufficient gene molecules to the site of interest. Herein, the rational design of surfactant-free lipo-polymersomes (LPPs) to overcome these problems is reported, simultaneously using a lipid-stabilized double emulsion approach. The LPPs are designed to conceal the cationic lipids and plasmid DNA inside the core along with iron oxide nanoparticles/polymer interlayer and a relatively neutral lipid shell to avoid the undesired interaction during circulation, leading to high accumulation in the tumors of mice. Furthermore, guided by an external magnetic field and the folic acid (FA) that target tumors via folate receptor-mediated endocytosis on the cell surface, the vectors demonstrate a 30-40-fold increase in cell uptake. Moreover, this synergistic tumor-targeted approach can enhance a 10-fold increase in in vivo transfection efficacy by promoting the delivery of LPPs to cancer cells and facilitating the endosomal escape of gene molecules. The new insights and capabilities represent a major step in nanovector engineering for safe and efficient gene delivery.
Copyright © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  gene delivery; iron oxide nanoparticles; nanocapsule; targeted

Mesh:

Substances:

Year:  2013        PMID: 23868864     DOI: 10.1002/adhm.201300122

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  8 in total

Review 1.  Lipid nanoparticles for gene delivery.

Authors:  Yi Zhao; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

2.  Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches.

Authors:  Jing Huang; Yuancheng Li; Anamaria Orza; Qiong Lu; Peng Guo; Liya Wang; Lily Yang; Hui Mao
Journal:  Adv Funct Mater       Date:  2016-02-05       Impact factor: 18.808

3.  Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissues.

Authors:  Dhirender Singh; JoEllyn M McMillan; Xin-Ming Liu; Hemant M Vishwasrao; Alexander V Kabanov; Marina Sokolsky-Papkov; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2014-03-19       Impact factor: 5.307

Review 4.  Trigger-Responsive Gene Transporters for Anticancer Therapy.

Authors:  Santhosh Kalash Rajendrakumar; Saji Uthaman; Chong Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2017-05-26       Impact factor: 5.076

Review 5.  Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review.

Authors:  Jinsong Zhang; Tianyuan Zhang; Jianqing Gao
Journal:  Nanomaterials (Basel)       Date:  2022-09-24       Impact factor: 5.719

6.  Polyethyleneimine-modified calcium carbonate nanoparticles for p53 gene delivery.

Authors:  Cen Chen; Huafeng Han; Wei Yang; Xiaoyuan Ren; Xiangdong Kong
Journal:  Regen Biomater       Date:  2016-01-13

7.  Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy.

Authors:  Jie Bai; Julie Tzu-Wen Wang; Kuo-Ching Mei; Wafa T Al-Jamal; Khuloud T Al-Jamal
Journal:  J Control Release       Date:  2016-07-19       Impact factor: 9.776

8.  Permeability of the Composite Magnetic Microcapsules Triggered by a Non-Heating Low-Frequency Magnetic Field.

Authors:  Ivan A Burmistrov; Maxim M Veselov; Alexander V Mikheev; Tatiana N Borodina; Tatiana V Bukreeva; Michael A Chuev; Sergey S Starchikov; Igor S Lyubutin; Vladimir V Artemov; Dmitry N Khmelenin; Natalia L Klyachko; Daria B Trushina
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.